Inventor
Volkhart Min-Jian Li
Inventor
Velbert, DE
Overview
Patents· 61 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes26%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
C07BGeneral methods of organic chemistry1%
C07KPeptides1%
C12NMicroorganisms or enzymes1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,736,896Substituted 5-fluoro-1H-pyrazolopyridines and their use202010,662,185Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use202010,292,970Heteroaryl-substituted imidazo[1,2-A]pyridines and their use201910,259,776Branched 3-phenylpropionic acid derivatives and their use201910,174,021Substituted pyrazolo[1,5-A]pyridines and their use201910,052,312Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use201810,023,528Branched 3-phenylpropionic acid derivatives and their use20189,993,476Substituted 5-flouro-1H-pyrazolopyridines and their use20189,884,063'Amido-substituted azole compounds'20189,776,997'3-aryl-substituted imidazo[1,2-A]pyridines and their use'20179,771,360'Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use'20179,688,699'3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines'20179,624,214'Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20179,605,008'Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof'20179,422,285'Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof'20169,387,203'Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof'20169,359,362'Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD'20169,309,198'N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase'20169,309,239'Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof'20169,266,885'Substituted 5-fluoro-1H-pyrazolopyridines and their use'20169,216,978'Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases'20159,174,997'4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof'20159,150,580'Substituted imidazopyridines and the use thereof'20159,126,998'Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20159,096,592'Bicyclic aza heterocycles, and use thereof'20159,090,609'Benzyl-substituted carbamates and use thereof'20159,090,610'Fluoroalkyl-substituted pyrazolopyridines and use thereof'20159,040,691'Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors'20159,018,414'Substituted 3-phenylpropionic acids and the use thereof'20159,018,258'Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof'20158,987,256'Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof'20158,946,215'Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20158,921,377'Substituted 5-fluoro-1H-pyrazolopyridines and their use'20148,889,700'4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use'20148,796,335'Branched 3-phenylpropionic acid derivatives and their use'20148,796,305'Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use'20148,778,964'Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use'20148,765,769'Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases'20148,691,817'Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof'20148,673,903'Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof'20148,642,592'Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof'20148,580,800'1,4-diaryl-pyrimidopyridazine-2,5-diones and their use'20138,569,314'Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD'20138,420,656'Substituted 5-fluoro-1H-pyrazolopyridines and their use'20138,343,987'Heterocyclic derivatives'20138,288,402'4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use'20128,227,511'Substituted chromanol derivatives and their use'20128,173,665'I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use'20128,124,775'Chemical compound and its use'20128,101,615'1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors'20128,097,629'Dihydropyridinone derivatives'20128,039,629'Chemical compound and its use'20118,003,787'Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors'20117,893,073'Heterocyclic derivatives'20117,691,854'Dihydropyridine derivatives for use as human neutrophil elastase inhibitors'20107,687,510'Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes'20107,566,723'1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use'20097,270,977'Polypeptides for identifying fungicidally active compounds'20077,230,017'Dihydropyridinone derivatives'20077,199,136'1,4-dihydro-1,4-diphenylpyridine derivatives'20076,046,034'Thermostable variants of human interferon-.gamma.(IFN-.gamma.)'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000Based in Cologne, DE· patent location history
2007–2020Based in Velbert, DE· patent location history
2012–2019Patents assigned to BAYER IP GMBH (28)· patent assignee history
2012–2020Patents assigned to Bayer Pharma AG (23)· patent assignee history
2012–2016Patents assigned to LI VOLKHART MIN-JIAN (20)· patent assignee history
2013–2016Patents assigned to STASCH JOHANNES-PETER (13)· patent assignee history
2013–2016Patents assigned to WUNDER FRANK (13)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAYER IP GMBH | 28 | 2012–2019 |
| Bayer Pharma AG | 23 | 2012–2020 |
| LI VOLKHART MIN-JIANself | 20 | 2012–2016 |
| STASCH JOHANNES-PETER | 13 | 2013–2016 |
| WUNDER FRANK | 13 | 2013–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Velbert, DE | 60 | 2007–2020 |
| Cologne, DE | 1 | 2000 |